Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia
· Delayed Price · Currency is AUD 12.33
+0.17 (1.40%)
At close: Dec 5, 2025
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 618.98 million as of December 5, 2025. Its market cap has decreased by -4.01% in one year.
Market Cap
618.98M
Enterprise Value
395.40M
Revenue
95.02M
Ranking
n/a
PE Ratio
17.17
Stock Price
12.33
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 618.98M, an increase of 11,744.90%. That is a compound annual growth rate of 21.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.01B |
| Pro Medicus | 26.57B |
| Cochlear | 17.94B |
| Sonic Healthcare | 11.43B |
| Ramsay Health Care | 8.59B |
| Ansell | 5.20B |
| Telix Pharmaceuticals | 4.84B |
| Mesoblast | 3.23B |